Article
Screening for mutations in exon 11 of the BRCA1 gene in 70 Italian breast and ovarian cancer patients by protein truncation test.
Oncogene - 19 Sept 1996
De Benedetti V M, Radice P, Mondini P, Spatti G, Conti A, Illeni M T, Caligo M A, Cipollini G, Bevilaqua G, Pilotti S, Pierotti M A
Abstract excerpt
The most common mutations in the familial breast and ovarian cancer susceptibility gene BRCA1 are frameshift and nonsense mutations, which lead to the synthesis of truncated proteins. On this ground, we have analysed BRCA1 exon 11, which includes about 61% of coding region, in germline DNA from 70 Italian breast and/or ovarian cancer patients, using the protein truncation test (PTT). BRCA1 mutations were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
